Nasdaq Biotech Index Surges Over 2.2% on June 26, Hits Fifth Consecutive Record Close

The Nasdaq Biotech Index rose over 2.2% on Friday, June 26, marking its fifth consecutive record closing. Pyxis Oncology led gainers with a 24.22% jump, while Humacyte, ATAI Beckley, Moderna, Immunitybio, GH Research, and Abcellera Biologics advanced 18.05% to 10.81%.

Omega Therapeutics (OMER) posted the steepest decline at 19.17%, followed by Mesoblast down 9.03% and Ardelyx down 8.50%, reflecting divergence within the sector.

Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments